Shamrock Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Shamrock Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$35K	Buy	689 +256	+59%	+$12K	0.03%	157
2019 Q2	$20K	Hold	433	–	–	0.01%	177
2019 Q1	$21K	Hold	433	–	–	0.02%	167
2018 Q4	$23K	Hold	433	–	–	0.03%	148
2018 Q3	$27K	Buy	+433	New	+$25.7K	0.02%	179
2016 Q4	–	Sell	-133	Closed	-$7K	–	258
2016 Q3	$7K	Hold	133	–	–	﹤0.01%	231
2016 Q2	$10K	Hold	133	–	–	0.01%	225
2016 Q1	$8K	Hold	133	–	–	﹤0.01%	214
2015 Q4	$9K	Hold	133	–	–	0.01%	218
2015 Q3	$8K	Hold	133	–	–	﹤0.01%	212
2015 Q2	$9K	Hold	133	–	–	﹤0.01%	216
2015 Q1	$9K	Hold	133	–	–	﹤0.01%	228
2014 Q4	$8K	Hold	133	–	–	﹤0.01%	211
2014 Q3	$7K	Hold	133	–	–	﹤0.01%	219
2014 Q2	$6K	Hold	133	–	–	﹤0.01%	250
2014 Q1	$7K	Buy	+133	New	+$7.08K	﹤0.01%	239

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shamrock Asset Management's BMY Position: Q3 2019 in Review

Shamrock Asset Management increased its Bristol-Myers Squibb (BMY) stake by 59% in Q3 2019, buying an estimated $12K and bringing the position to 689 shares worth $35K. The position accounts for 0.03% of the portfolio, ranked #157.

Shamrock Asset Management first reported a position in BMY in Q1 2014 and has held it in 16 quarters since. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Shamrock Asset Management held 689 shares of Bristol-Myers Squibb worth $35K as of Q3 2019.
Shamrock Asset Management bought 256 Bristol-Myers Squibb shares in Q3 2019, an estimated $12K.
Bristol-Myers Squibb made up 0.03% of Shamrock Asset Management's portfolio in Q3 2019, its #157 holding.
Shamrock Asset Management first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 16 quarters since.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.